MetaBiom
Microbiome & Chronic Diseases

Evidence Based Medicine
Sign in

Bifidobacteria ⇒ Clostridiales {10000259}

Record Keys


Organism:
Bifidobacteria
Parent:

Details


Initialisation date:
2020-10-01

Meta Information


Rank:
Genus
Domain:
Bacteria
Zone:[  ]
Enzyme:[  ]
Function:[  ]

Notes:


[  ]

References Notes


[  ]

Shared Reference Notes


  • [1.13
    - The reduction of Bifidobacteria, the main producers of lactic acid capable of suppressing the growth of pathogenic bacteria, leads to an alteration of the immunitary system.
  • [1.14] [#High-fiber diet
    - Dietary fiber > competitive advantage to Bifidobacteria
  • [1.15
    - Loss of Bifidobacterium early in life has been associated with increased risk of developing autoimmunity, as seen in a birth cohort in Finland and atopic wheeze in another cohort in rural Ecuador.
  • [1.16] [#Premature infant
    - At the phylum level, #Firmicutes were the dominant phylum in 95% of all meconium samples (highest abundance observed in the VPT neonates as compared to PT and FT neonates); the second most dominant phylum was Bacteroidetes in 50% of all meconium samples.
  • [1.7] [#Antibiotic Therapy
    - Macrolide exposure was associated with reduced richness for twice as long as penicillin. - Antbiotic at childhud > reduced Bifidobacteria (5 studies) and #Lactobacillus (2 studies), and significant increases in #Proteobacteria such as E. coli (4 studies).
  • [1.5
    - #Garlic-fructan'>##Garlic fructan were found to selectively stimulate the growth of beneficial Bifidobacteria from human fecal microflora.
  • [1.2] [#Covid-19
    -anti-inflammatory bacteria, including Bifidobacteria species and #Eubacterium rectale, with lower severity, and pro-inflammatory bacteria such as #Prevotella copri with higher severity.

Common References